News Coverage Archives - STAR Therapeutics

#E79242

Promising Star formations draw investors in $90M oversubscribed series C
Gallery
Promising Star formations draw investors in $90M oversubscribed series C

News Coverage

Promising Star formations draw investors in $90M oversubscribed series C

Star Therapeutics Inc. brought on board six new investors in its oversubscribed $90 million series C round, raising the company’s total funding to more than $190 million since its founding in 2018 to advance in-house drug discovery efforts via formation of portfolio companies. Since emerging from stealth in early...

By Jennifer Boggs, BioWorld|2023-09-15T15:42:40-04:00September 5, 2023|News Coverage|0 Comments

Stars align as ex-True North team nabs another $90M to build out biotech constellation

Star Therapeutics, which created two antibody-focused biotech startups with more in the works, has now reeled in a $90 million Series C. The round, disclosed Tuesday morning, brings the Bay Area biotech’s total financing to more than $190 million since emerging from Westlake Village BioPartners in early 2022. Star’s biotech startups Vega Therapeutics and Electra Therapeutics...

By Kyle LaHucik, Endpoints|2023-09-15T15:44:01-04:00September 5, 2023|News Coverage|0 Comments

Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies

Investors have showered Star Therapeutics with $90 million to grow its portfolio companies and develop new antibody drugs for diseases with high unmet need. Sofinnova Investments led the oversubscribed series C round and was joined by new investors Qatar Investment Authority, Catalio Capital Management, Agent Capital, Soleus Capital and NYBC Ventures alongside all seven...

By Gabrielle Masson, FIERCE Biotech|2023-09-15T15:44:45-04:00September 5, 2023|News Coverage|0 Comments

Asked and Answered: Follow the Biology
Gallery
Asked and Answered: Follow the Biology

News Coverage

Asked and Answered: Follow the Biology

Adam Rosenthal is the CEO and founder of Star Therapeutics, [...]

By By Damian Doherty, Inside Precision Medicine|2023-01-05T15:54:12-05:00December 23, 2022|News Coverage|0 Comments

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.